Injective rallies as Vulcan mainnet upgrade proposal governance vote gains traction
Injective (INJ) is trading at $6.85, up 7.18% on the day and currently sits well above its key moving averages. The asset has displayed robust intraday momentum and remains positioned in strong territory relative to its recent trend baseline.
Highlights
- Injective initiated a governance vote on the Vulcan mainnet upgrade, empowering INJ stakers in protocol decision-making and execution enhancements.
- Strong network participation and alignment of upgrades with community input are fueling heightened demand and optimism among INJ stakeholders.
- INJ remains in a bullish uptrend above key supports, but overbought signals heighten risk of near-term pullback or range consolidation between $6.85 and $7.25.
Governance upgrade vote boosts network engagement and demand
Injective has launched a governance vote for its Vulcan mainnet upgrade proposal, enabling INJ stakers to participate directly in decisions regarding execution improvements, on-chain module upgrades, and enhanced buyback mechanics. The voting process signals increased network engagement and underscores the project's efforts to advance scalability and efficiency, with proposed changes directly tied to community input. This active governance event is reinforcing demand for INJ and is closely followed by stakeholders anticipating positive shifts in the protocol’s operational dynamics.
Overbought metrics signal short-term risk amid bullish momentum
On the technical front, INJ is well supported above the MA-20 ($5.35), MA-50 ($4.28), and MA-200 ($4.24), with the Ichimoku Kijun level at $5.41 providing immediate backup. INJ traded in a volatile $6.43–$6.88 range after opening with a slight upside gap ($6.39 to $6.55), reaching session highs near $6.88. Momentum indicators remain strong as both MACD and ADX highlight persistent buying strength, while oscillators such as RSI (73.87), Stoch RSI (87.64), and CCI (182.27) show clear overbought conditions. BBP at 1.00 confirms intraday buyer dominance, and the Awesome Oscillator affirms the prevailing uptrend, though a divergence between overbought oscillators and bullish momentum suggests risk of a short-term pullback.
Sideways consolidation likely as overextension tempers further gains
For the next five trading days, INJ is expected to remain in a $6.85 to $7.25 band, reflecting typical volatility at current levels. The probability of further gains is under 20%, so a decrease scenario is more likely if overbought conditions prompt a correction. The most probable outcome is short-term consolidation in a sideways pattern just below resistance, while a decisive break above $7.25 could spur continuation higher. Should INJ retreat below $6.85, the risk of a deeper short-term correction may quickly intensify.
Earlier, analysts noted that Injective's medium-term momentum remained constructive but was tempered by signs of overbought conditions and the potential for heightened market volatility. The current technical landscape strengthens this view, as persistent upside momentum is now counterbalanced by increased risk of a short-term pullback, making the price reaction to a break above $7.25 or below $6.85 a key signal for the next directional move.
Latest Injective News
- Forex
- Crypto